Merck Cuts Jobs and Costs

Merck is slashing costs and jobs as it battles competition from cheaper generic drugs and a stalled pipeline of new medications. Mary Thompson reports for NBR on Merck’s restructuring and looks at what’s next for the pharmaceutical giant.

This entry was posted in Health Care. Bookmark the permalink.

Leave a Reply